Abstract
Background and aimsLEVO is a novel inodilator developed to treat heart failure. Biotransformation of LEVO in the intestinal tract gives rise to intermediate metabolites with prolonged beneficial haemodynamic effects. There...
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have